alendronate has been researched along with strontium in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (66.67) | 29.6817 |
2010's | 2 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bilezikian, JP; Rubin, MR | 1 |
Shiraki, M | 1 |
Coxon, FP; Crockett, JC; Rogers, MJ; Thompson, K | 1 |
Mosekilde, L; Pinholt, EM; Rejnmark, L; Schwartz, K; Vestergaard, P | 1 |
Bigi, A; Boanini, E; Fini, M; Giavaresi, G; Parrilli, A; Salamanna, F; Torricelli, P | 1 |
2 review(s) available for alendronate and strontium
Article | Year |
---|---|
New anabolic therapies in osteoporosis.
Topics: Alendronate; Bone and Bones; Bone Resorption; Drug Therapy, Combination; Female; Fluorides; Human Growth Hormone; Humans; Insulin-Like Growth Factor I; Osteogenesis; Osteoporosis, Postmenopausal; Parathyroid Hormone; Strontium | 2002 |
[Treatment of osteoporosis--a new paradigm].
Topics: Alendronate; Bone Density; Cholecalciferol; Diphosphonates; Drug Design; Fractures, Bone; Humans; Osteoporosis; Parathyroid Hormone; Reference Standards; Risk; Selective Estrogen Receptor Modulators; Strontium | 2004 |
4 other study(ies) available for alendronate and strontium
Article | Year |
---|---|
Strontium: new drug. Postmenopausal osteoporosis: too many unknowns.
Topics: Aged; Aged, 80 and over; Alendronate; Bone Density; Bone Density Conservation Agents; Calcium; Clinical Trials as Topic; Female; Fractures, Bone; Humans; Middle Aged; Osteoporosis, Postmenopausal; Strontium; Teriparatide; Treatment Outcome; Vitamin D | 2005 |
Cytosolic entry of bisphosphonate drugs requires acidification of vesicles after fluid-phase endocytosis.
Topics: Alendronate; Animals; Biological Transport; Calcium; Cell Line; Clodronic Acid; Cytosol; Egtazic Acid; Endocytosis; Flow Cytometry; Fluorescent Dyes; Kinetics; Macrophages; Mice; Microscopy, Confocal; Strontium | 2006 |
Oral bisphosphonate use increases the risk for inflammatory jaw disease: a cohort study.
Topics: Administration, Oral; Aged; Alcoholism; Alendronate; Bisphosphonate-Associated Osteonecrosis of the Jaw; Bone Density Conservation Agents; Case-Control Studies; Cohort Studies; Denmark; Diabetes Complications; Diphosphonates; Drug Therapy; Etidronic Acid; Female; Humans; Jaw Diseases; Male; Neoplasms; Organometallic Compounds; Osteitis; Osteomyelitis; Osteoporosis; Parathyroid Hormone; Periostitis; Radiotherapy; Raloxifene Hydrochloride; Risk Factors; Sjogren's Syndrome; Strontium; Thiophenes | 2012 |
Antiresorptive properties of strontium substituted and alendronate functionalized hydroxyapatite nanocrystals in an ovariectomized rat spinal arthrodesis model.
Topics: Alendronate; Animals; Arthrodesis; Biocompatible Materials; Durapatite; Female; Lumbar Vertebrae; Ovariectomy; Rats; Strontium | 2019 |